Literature DB >> 15700618

Early stages of HIV replication: how to hijack cellular functions for a successful infection.

Jacqueline Lehmann-Che1, Ali Saïb.   

Abstract

From the cell surface to the nucleus, the human immunodeficiency virus type 1 (HIV-1) will face multiple obstacles, crossing the plasma and nuclear membranes, but also finding its path within the cytoplasm in which elements from the cytoskeleton, organelles, and high a protein concentration, limit intracellular movements. At the same time, HIV-1 has to counteract cellular defenses--known as restriction factors--interfering with early steps of the virus cycle. Although the general outcomes of these early stages have been identified since several decades, the stepwise interactions taking place between cellular and viral components during this early journey, which will transform the incoming viral-RNA genome into a double-strand DNA competent for integration, remain largely unknown. In that sense, the uncoating process and the molecular basis of intracellular trafficking of preintegration complexes (PICs) are still poorly defined. Additionally, other key stages, which have been the focus of many reports, still require some clarifications, as is the case for the precise determinants of nuclear import of PICs. Finally, whereas the molecular mechanisms of integration, the last event of the early phase of retroviral life cycle, are now well understood, the choice of the integration site remains mysterious. Fully elucidating the early steps of HIV-1 replication is therefore crucial, not only for developing new antiretroviral drugs, but also for improving the design of lentiviral vectors for gene therapy. Since the mechanisms of HIV-1 entry and innate cell defenses were recently the topic of excellent reviews, we will focus here on uncoating and intracellular trafficking of HIV-1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15700618

Source DB:  PubMed          Journal:  AIDS Rev        ISSN: 1139-6121            Impact factor:   2.500


  9 in total

Review 1.  The structural biology of HIV assembly.

Authors:  Barbie K Ganser-Pornillos; Mark Yeager; Wesley I Sundquist
Journal:  Curr Opin Struct Biol       Date:  2008-04-09       Impact factor: 6.809

2.  TSG101 exposure on the surface of HIV-1 infected cells: implications for monoclonal antibody therapy for HIV/AIDS.

Authors:  Leyla Diaz; Hanwen Mao; Yu Zhou; Manu Kohli; Josephine Cassella; David Santos; Zena Fesseha; Ke Weng; Hanson Chen; Douty Bamba; James D Marks; Michael Goldblatt; Michael Kinch
Journal:  Am J Transl Res       Date:  2010-07-20       Impact factor: 4.060

3.  Meeting of conventional and unconventional pathways at the TGN.

Authors:  Gaudeline Rémillard-Labrosse; Roger Lippé
Journal:  Commun Integr Biol       Date:  2009-09

4.  FGI-104: a broad-spectrum small molecule inhibitor of viral infection.

Authors:  Michael S Kinch; Abdul S Yunus; Calli Lear; Hanwen Mao; Hanson Chen; Zena Fesseha; Guangxiang Luo; Eric A Nelson; Limin Li; Zhuhui Huang; Michael Murray; William Y Ellis; Lisa Hensley; Jane Christopher-Hennings; Gene G Olinger; Michael Goldblatt
Journal:  Am J Transl Res       Date:  2009-01-05       Impact factor: 4.060

Review 5.  Revisiting HIV-1 uncoating.

Authors:  Nathalie Arhel
Journal:  Retrovirology       Date:  2010-11-17       Impact factor: 4.602

6.  Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells.

Authors:  Jonathan Bertin; Corinne Barat; Dave Bélanger; Michel J Tremblay
Journal:  J Neuroinflammation       Date:  2012-03-16       Impact factor: 8.322

7.  HIV infection of non-dividing cells: a divisive problem.

Authors:  Ariberto Fassati
Journal:  Retrovirology       Date:  2006-10-26       Impact factor: 4.602

Review 8.  Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis.

Authors:  Jingyi Li; Chunfen Mo; Yifan Guo; Bowen Zhang; Xiao Feng; Qiuyue Si; Xiaobo Wu; Zhe Zhao; Lixin Gong; Dan He; Jichun Shao
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

9.  HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Dominique Coulaud; Laurence Hameau; Sophie Lafosse; Josette Jeusset; Isabelle Borde; Michèle Reboud-Ravaux; Tobias Restle; Robert J Gorelick; Eric Le Cam
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.